timolol has been researched along with Cancer of Head in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bhullar, S; Coleman, EL; Leventhal, JS; Olamiju, B | 1 |
| Admani, S; Borok, J; Friedlander, SF; Gangar, P; Proudfoot, J | 1 |
| Kazandjieva, J; Semkova, K | 1 |
| Beroukhim, K; Rotunda, AM | 1 |
| Cao, RY; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L | 1 |
| Chakkittakandiyil, A; Pope, E | 1 |
| Blatt, J; Buck, S; Burkhart, CN; Gold, S; Morrell, DS; Powell, C; Stavas, J; Zdanski, C | 1 |
1 trial(s) available for timolol and Cancer of Head
| Article | Year |
|---|---|
Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.
Topics: Administration, Topical; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Prospective Studies; Scalp; Skin Neoplasms; Timolol; Treatment Outcome | 2018 |
6 other study(ies) available for timolol and Cancer of Head
| Article | Year |
|---|---|
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Angiolymphoid Hyperplasia with Eosinophilia; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cryotherapy; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Paronychia; Protein Kinase Inhibitors; Retrospective Studies; Severity of Illness Index; Silver Nitrate; Timolol; Treatment Outcome | 2021 |
Rapid complete regression of an early infantile hemangioma with topical timolol gel.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Gels; Head and Neck Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Scalp; Skin Neoplasms; Timolol; Treatment Outcome | 2014 |
Topical 0.5% timolol heals a recalcitrant irradiated surgical scalp wound.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Mohs Surgery; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Scalp; Skin Neoplasms; Timolol; Wound Healing | 2014 |
Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Blood Glucose; Blood Pressure; Female; Follow-Up Studies; Head and Neck Neoplasms; Heart Rate; Hemangioma; Humans; Infant; Male; Photography; Remission Induction; Safety; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Topical timolol gel for infantile hemangiomas: a pilot study.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Child, Preschool; Female; Gels; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Pilot Projects; Retrospective Studies; Timolol; Treatment Outcome | 2010 |
β-blockers for infantile hemangiomas: a single-institution experience.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Monitoring; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Laryngeal Neoplasms; Liver Neoplasms; Male; Propranolol; Retrospective Studies; Timolol | 2011 |